Goksu, S. Et Al. 2015. Factors predicting lapatinib efficacy in HER-2+metastatic breast carcinoma: Does it work better in different histologic subtypes?. INDIAN JOURNAL OF CANCER , vol.52, no.4 , 517-519.

Goksu, S., BOZCUK, H. Ş., Koral, L., ÇAKAR, B., GUNDUZ, S., TATLI, A. M., ... ARSLAN, D.(2015). Factors predicting lapatinib efficacy in HER-2+metastatic breast carcinoma: Does it work better in different histologic subtypes?. INDIAN JOURNAL OF CANCER , vol.52, no.4, 517-519.

Goksu, SEMA Et Al. "Factors predicting lapatinib efficacy in HER-2+metastatic breast carcinoma: Does it work better in different histologic subtypes?," INDIAN JOURNAL OF CANCER , vol.52, no.4, 517-519, 2015

Goksu, SEMA S. Et Al. "Factors predicting lapatinib efficacy in HER-2+metastatic breast carcinoma: Does it work better in different histologic subtypes?." INDIAN JOURNAL OF CANCER , vol.52, no.4, pp.517-519, 2015

Goksu, S. Et Al. (2015) . "Factors predicting lapatinib efficacy in HER-2+metastatic breast carcinoma: Does it work better in different histologic subtypes?." INDIAN JOURNAL OF CANCER , vol.52, no.4, pp.517-519.

@article{article, author={SEMA SEZGİN GÖKSU Et Al. }, title={Factors predicting lapatinib efficacy in HER-2+metastatic breast carcinoma: Does it work better in different histologic subtypes?}, journal={INDIAN JOURNAL OF CANCER}, year=2015, pages={517-519} }